Biomerieux (Paris:BIM)

bioMérieux, a world leader in microbiology and in vitro diagnostics, offers innovative solutions for the detection of infectious diseases and food safety. The French company, with a century of family expertise, is expanding internationally while maintaining a growth-oriented strategy in emerging fields such as molecular biology, offering a stable stock profile despite a moderate return.

Biomerieux (Paris:BIM) Read More »

Diary of a future rentier (8)

This post is part 8 of 86 in the series Diary of a future rentier

The surprising journey of a man confronted with gender bias in his search for part-time employment, despite his experience and skills. A reflection on persistent discrimination in the professional world, where the quest for a balance between private life and career still comes up against gender stereotypes in the 21st century.

Diary of a future rentier (8) Read More »

Performance 2012

The performance of the CHF portfolio was positive in 2012, reaching +10.17%, thanks to a strong first half. However, its defensive vocation translates into an annual return since launch of +7.76%, and a performance below that of the market during the bullish phases.

Performance 2012 Read More »